Patent US5489589A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5489589A Expired / Lapsed US ⏱️ 0.0 years remaining

Amino acid derivatives of paclitaxel

Assignee: Bristol Myers Squibb Co
•
Filing: 1994-12-07
•
Granted: 1996-02-06
•
Expires: 2014-12-07
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The present invention concerns water-soluble amino acid derivatives of paclitaxel, their use as antitumor agents, and pharmaceutical compositions containg the compounds.

Inventors

  • 👤 Mark D. Wittman
  • 👤 John F. Kadow

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-02 20:04
CPC Classifications
C; C07; C07D; C07D305/00; C07D305/14; A; A61; A61P; A61P35/00

Claims Analysis

Total Claims: 12
Claim 1
Independent Claim 164 words
A compound of the formula (I): ##STR30## wherein R 1 or R 2 are independently hydrogen or --(CH 2 O)) n COCH 2 Y; R 6 is hydrogen, C 1-8 alkanoyl or --(CH 2 O) n COCH 2 Y; n is one to six; p is zero or one; R 4 and R 5 are independently C 1-8 alkyl, C 2-8 alkenyl, C 2-8 alkynyl, or --Z--R 7 ; Z is a direct bond, C 1-8 alkylene or C 2-8 alkenediyl; R 7 is aryl, substituted aryl, C 3-8 cycloalkyl or heteroaryl; R 3 is hydrogen, C 1-8 alkyl, C 2-8 alkenyl, C 2-8 alkynyl, C 3-8 cycloalkyl, aryl or heteroaryl; Y is a radical of the formula ##STR31## in which q is one to three; R r is hydrogen or C 1-8 alkyl; and with the proviso at least one of R 1 , R 2 and R 6 is --(CH 2 O) n COCH 2 Y; or a pharmaceutically acceptable salt thereof.
Claim 2
Dependent Claim 164 words
A compound of the formula (I): ##STR30## wherein R 1 or R 2 are independently hydrogen or --(CH 2 O)) n COCH 2 Y; R 6 is hydrogen, C 1-8 alkanoyl or --(CH 2 O) n COCH 2 Y; n is one to six; p is zero or one; R 4 and R 5 are independently C 1-8 alkyl, C 2-8 alkenyl, C 2-8 alkynyl, or --Z--R 7 ; Z is a direct bond, C 1-8 alkylene or C 2-8 alkenediyl; R 7 is aryl, substituted aryl, C 3-8 cycloalkyl or heteroaryl; R 3 is hydrogen, C 1-8 alkyl, C 2-8 alkenyl, C 2-8 alkynyl, C 3-8 cycloalkyl, aryl or heteroaryl; Y is a radical of the formula ##STR31## in which q is one to three; R r is hydrogen or C 1-8 alkyl; and with the proviso at least one of R 1 , R 2 and R 6 is --(CH 2 O) n COCH 2 Y; or a pharmaceutically acceptable salt thereof.
Claim 3
Dependent Claim 31 words
A compound of claim 1 in which R 6 is acetyl; R 2 is hydrogen; R 4 is phenyl; p is zero; R 5 is phenyl; and R 3 is methyl.
Claim 4
Dependent Claim 8 words
The compound of claim 2 that is 7-O-[[[-(4-methyl-1-piperaznyl)acetyl]oxy]methoxy]paclitaxel.
Claim 5
Dependent Claim 8 words
The compound of claim 2 that is 7-O-[-(N,N-diethlaminoacetyl)oxy]methoxy]paclitaxel.
Claim 6
Dependent Claim 8 words
The compound of claim 2 that is 7-O-[[[[-(4-methyl-1-piperazinyl)acetyl]oxy]methoxy]methoxy]paclitaxel.
Claim 7
Dependent Claim 8 words
The compound of claim 2 that is 7-O-[[(morpholinoacetyl)oxy]methoxy]paclitaxel.
Claim 8
Dependent Claim 8 words
The compound of claim 2 that is 7-O-[-(N,N-dimethylaminoacetyl)oxy]methoxy]paclitaxel.
Claim 9
Dependent Claim 31 words
A compound of claim 1 in which R 6 is acetyl; R 1 is hydrogen; R 4 is phenyl; p is zero; R 5 is phenyl; and R 3 is methyl.
Claim 10
Dependent Claim 8 words
The compound of claim 8 that is 2'-O-[[[[-(4-methyl-1-piperazinyl)acetyl]oxy]methoxy]methoxy]paclitaxel.
Claim 11
Dependent Claim 20 words
A pharmaceutical composition which comprises an antitumor effective amount of a compound of claim 1 and a pharmaceutically acceptable carrier.
Claim 12
Dependent Claim 27 words
A method for inhibiting tumor growth in a mammalian host which comprises administering to said mammal a tumor-growth inhibiting amount of a compound of a claim 1.

References Cited (Backward Citations)

US4942184A Cited
US4960790A Cited
US5059699A Cited
EP0558959A1 Cited
EP0569281A1 Cited
EP0604910A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1999-02-05 1999-08-07 2000-02-06 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2003-02-05 2003-08-07 2004-02-06 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2007-02-05 2007-08-07 2008-02-06 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag